The ASCO Annual Meeting enters its second year in a virtual setting June 4-8, 2021, to ensure the safety and health of attendees while delivering groundbreaking science in oncology and timely information on clinical application and treatment new scientific data to the oncology community.


ASCO’s robust scientific and education meeting platform will provide attendees with live and on-demand access to top caliber scientific research presentations and slides. The online meeting experience will also offer opportunities to engage with and learn from oncology thought leaders from around the world, including interactivity and live question and answer in key sessions.


Expected pivotal trials: Keep an Eye Out For…


First results of a head-to-head trial of acalabrutinib versus ibrutinib in previously treated chronic lymphocytic leukemia. (Abstract 7500)


Acalabrutinib ± obinutuzumab versus obinutuzumab + chlorambucil in treatment-naïve chronic lymphocytic leukemia: Elevate-TN four-year follow up. (Abstract 7509)


ESCALADE: A phase 3 study of acalabrutinib in combination with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for patients ≤65y with untreated non-germinal center B-cell–like (non-GCB) diffuse large B-cell lymphoma (DLBCL). (Abstract: TPS7572)


Fixed-duration (FD) first-line treatment (tx) with ibrutinib (I) plus venetoclax (V) for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL): Primary analysis of the FD cohort of the phase 2 captivate study. (Abstract 7501)


Survival trends in chronic lymphocytic leukemia in the era of oral targeted therapies in the United States: SEER database analyses (1985 to 2017). (Abstract 7524)


Up to seven years of follow-up in the RESONATE-2 study of first-line ibrutinib treatment for patients with chronic lymphocytic leukemia. (Abstract 7523)


And many more!




Registration for the Meeting is open and includes access all Education and Scientific Sessions, Poster Sessions, Online Exhibits, 2021 ASCO Annual Meeting Videos and Slides, Annual Meeting Proceedings, and ASCO Educational Bookas well as access to an online platform with interactive tools and Q&A.


Access to Content


Content will be delivered in two formats: on-demand and through a scheduled broadcast. The on-demand content will be comprised of 175 sessions—formats include Oral Abstract Sessions, Poster Sessions, Poster Discussion Sessions, and track-specific Clinical Science Symposia—and will be available on June 4 at 9:00 AM EST.


The scheduled broadcast will include 48 high-impact sessions with real-time engagement, live Q&A, and unparalleled learning; these sessions will begin on June 4 at 11:00 AM EST. Sessions will be available on-demand 2 hours after airing. Search the Digital Program and the Broadcast Schedule to plan your meeting experience.


For more information, visit: ASCO 2021 Annual Meeting